Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Bernstein analyst Courtney Breen maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) yesterday and set a price target of ...

The case was made more complex because the plaintiff, who was 36 at the time of the crash, had prior back problems.

The case was made more complex because Gosinanonth, who was 36 at the time of the crash, had prior back problems, Hall said.

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s ...

This was the stock's second consecutive day of losses.

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

The kidney transplant rejection prophylaxis market is projected to experience steady growth, driven by the introduction of innovative therapi ...

Additional collaborators on the pilot test include The University of Texas MD Anderson Cancer Center, Houston; The University ...

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStoptm for the treatment of acid reflux, a treatment field ...

USA News Group News Commentary ? Weeks after the monumental $500-billion announcement of Project Stargate, which includes aims to transform healthcare, a growing number of health executives are seeing ...

This was the stock's third consecutive day of losses.